Evaluation and Management of Significant Short-Term Memory Loss in Older Adults

Initial Cognitive Assessment

The American College of Physicians recommends performing structured cognitive testing at the first visit, using tools such as the Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE), to assess cognitive function in older adults with significant short-term memory loss 1, 2
The Clock Drawing Test can be used as a supplementary screening tool to assess cognitive function in older adults with significant short-term memory loss 1
Baseline cognitive performance should be documented across all domains, including memory, executive function, visuospatial abilities, language, and behavior, to identify areas of impairment in older adults with significant short-term memory loss 1

The American Geriatrics Society recommends assessing the impact of cognitive symptoms on instrumental activities of daily living, such as managing finances, medications, transportation, household management, cooking, and shopping, to determine the level of functional impairment in older adults with significant short-term memory loss 1
The Pfeffer Functional Activities Questionnaire (FAQ) or Disability Assessment for Dementia (DAD) can be used to evaluate functional abilities in older adults with significant short-term memory loss, with input from both the patient and informant 1

The American Psychiatric Association recommends screening for neuropsychiatric symptoms and depression in older adults with significant short-term memory loss, using tools such as the Neuropsychiatric Inventory-Questionnaire (NPI-Q) or Mild Behavioural Impairment Checklist (MBI-C), as these conditions can contribute to cognitive impairment 1, 3, 2

The American College of Physicians recommends ordering laboratory tests, including thyroid function tests (TSH, free T4), vitamin B12 and folate levels, complete blood count (CBC), and comprehensive metabolic panel, to identify reversible causes of cognitive impairment in older adults with significant short-term memory loss 1, 4

The American Academy of Neurology recommends obtaining structural brain imaging, preferably MRI, to detect vascular lesions and other abnormalities that may contribute to cognitive impairment in older adults with significant short-term memory loss 1

The American Diabetes Association recommends screening for cognitive impairment annually in diabetic patients starting at age 65, and setting individualized glycemic targets to minimize hypoglycemia risk 3, 4
The American Geriatrics Society recommends avoiding hypoglycemia diligently, as it increases the risk of cognitive decline in older adults with diabetes 3

The American Psychiatric Association recommends integrating all findings to determine if dementia is present, and differentiating mild cognitive impairment from dementia based on the level of interference with daily functioning 1, 5

The American Academy of Neurology recommends referring patients with confirmed dementia to neurology or geriatrics for formal neuropsychological evaluation, and considering cholinesterase inhibitors for mild to moderate Alzheimer's disease 5, 1, 6, 7
The American Geriatrics Society recommends implementing cognitive stimulation therapy and educating caregivers about dementia, communication strategies, and establishing structured routines 2

The American College of Physicians recommends scheduling regular reassessment every 6-12 months to track disease progression, using a multi-dimensional approach to monitor cognition, functional autonomy, behavioral symptoms, and caregiver burden 1, 2